Skip to main content
Premium Trial:

Request an Annual Quote

Conferences and Deadlines

Premium

Deadlines

September 18 — Applications due in response to NIH RFA-E-06-004, Biology Elucidation of Environmental Pathways and Susceptibility. The goal of this RFA is to solicit applications that promote the understanding of pathways and/or networks that, when perturbed by environmental factors, stressors, or alcohol, alter the susceptibility to complex human diseases.

September 20 — First application due date for NIH’s Bioengineering Research Partnerships, PAR-06-456. This program announcement’s primary objective is to encourage basic, applied, and translational bioengineering research that could make a significant contribution to improving human health.

September 22 — Letters of intent due to NIH for RFA-RM-06-010, Using Metabolomics to Investigate Biological Pathways and Networks. A total amount of $3.8 million will be awarded in FY07 for this initiative, which seeks to encourage the use of metabolomics to advance the understanding of pathways and networks, their temporal and spatial resolution, and their regulation in health and disease states.

September 22 — Preliminary proposal due date for NSF 06-579, Frontiers in Integrative Biological Research. This program encourages PIs to identify unanswered or under-studied questions in biology and to use innovative approaches to address them.

September 24 — Application due date for NIH’s Innovations in Biomedical Computational Science and Technology and Exploratory Innovations in Biomedical Computational Science and Technology, PAR-06-410 and PAR-06-411 respectively.

October 6 — Full proposal target date for NSF’s Plant Genome Research Program (PGRP), program solicitation 06-581. PGRP covers genome-wide research questions in plant biology, the transfer of basic biological findings from model systems to plants of economic importance, and the development of novel technologies for plant genomics.

October 9 — Full proposal target date for NSF 05-600, Microbial Observatories and Microbial Interactions and Processes activities. These awards will support research to discover and characterize novel microorganisms, microbial consortia, communities, activities and other novel properties, and to study their roles in diverse environments.

October 12-13 — Philadelphia’s Doubletree Hotel hosts Statistical Learning and Data Mining II: Tools for Tall and Wide Data, a two-day course given by Trevor Hatie and Robert Tibshirani of Stanford University.

October 13 — First day to submit applications in response to the NIH RFA Biomarker Development for Diabetic Complications, DK-06-004. Investigators are invited to propose exploratory and developmental research on biomarkers for complications of diabetes.

December 7 — Full proposals due in response to NSF solicitation 06-888, Computational Mathematics, which supports mathematical research in areas of science where computing plays a central and essential role, emphasizing algorithms, numerical methods, and symbolic methods.

December 12 — Letters of intent due in response to the funding announcement for Targeting Diseases Caused by Protein Misfolding or Misprocessing (R01 and R21, PAR-06-479 and PAR-06-480).

File Attachments
The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.